Bio-Rad Laboratories, Inc. Stock Deutsche Boerse AG
Stocks
BUWA
US0905722072
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 281.70 EUR | -0.11% |
|
+1.23% | +9.54% |
| 02/07 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 03/06 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
| Market Cap | 8.66B 7.52B 7B 6.43B 12.14B 826B 12.33B 82.55B 32.4B 411B 32.51B 31.79B 1,379B | P/E 2026 * |
39.2x | P/E 2027 * | 38.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.91B 6.87B 6.4B 5.87B 11.09B 755B 11.26B 75.41B 29.6B 376B 29.69B 29.04B 1,260B | EV / Sales 2026 * |
3.08x | EV / Sales 2027 * | 2.92x |
| Free-Float |
60.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | -0.11% | ||
| 1 week | +1.23% | ||
| Current month | +9.20% | ||
| 1 month | +7.60% | ||
| 3 months | +27.36% | ||
| 6 months | +11.50% | ||
| Current year | +9.54% |
| 1 week | 274 |  | 290.8 |
| 1 month | 246.4 | | 290.8 |
| Current year | 204.6 | | 290.8 |
| 1 year | 204.6 | | 294.7 |
| 3 years | 187.35 | | 367.8 |
| 5 years | 187.35 | | 700 |
| 10 years | 128.88 | | 700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.11% | +1.23% | - | - | 8.66B | |
| -0.11% | +2.19% | -16.54% | -5.40% | 183B | |
| -0.48% | +2.26% | -5.71% | -3.04% | 110B | |
| +0.03% | +0.43% | +8.79% | +66.52% | 60.75B | |
| +3.50% | -0.66% | +30.35% | +55.04% | 50.01B | |
| -0.29% | +5.40% | -7.54% | -40.85% | 45.59B | |
| -0.77% | -0.04% | - | - | 33.08B | |
| +11.00% | +15.48% | +2.28% | -33.67% | 28.76B | |
| +0.19% | +3.43% | +41.88% | -7.76% | 23.9B | |
| -0.74% | +6.94% | +1.07% | +1.49% | 22.53B | |
| Average | +1.19% | +4.36% | +6.82% | +4.04% | 61.9B | |
| Weighted average by Cap. | +0.63% | +5.48% | -1.62% | +4.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.23B 2.08B 1.91B 3.6B 245B 3.66B 24.49B 9.61B 122B 9.64B 9.43B 409B | 2.63B 2.29B 2.13B 1.96B 3.7B 252B 3.75B 25.13B 9.86B 125B 9.9B 9.68B 420B |
| Net income | 225M 196M 182M 167M 316M 21.48B 321M 2.15B 842M 10.69B 845M 826M 35.86B | 230M 200M 186M 171M 323M 21.96B 328M 2.19B 861M 10.93B 864M 845M 36.65B |
| Net Debt | -749M -651M -606M -556M -1.05B -71.5B -1.07B -7.14B -2.8B -35.6B -2.81B -2.75B -119B | -965M -839M -781M -717M -1.35B -92.16B -1.38B -9.21B -3.61B -45.88B -3.63B -3.55B -154B |
| Date | Price | Change |
|---|---|---|
| 01/08/26 | EUR 280.20 | -0.64% |
| 30/07/26 | EUR 282.00 | -1.12% |
| 29/07/26 | EUR 285.20 | -1.93% |
| 28/07/26 | EUR 290.80 | +4.60% |
| 27/07/26 | EUR 278.00 | +0.43% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BUWA Stock
Select your edition
All financial news and data tailored to specific country editions
